Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharma among 4 stocks to hit 52-week highs & rally up to 25% in a month
The Sensex ended higher as select BSE 200 stocks touched fresh 52-week highs. FSN E-Commerce Ventures, Titan, Sun Pharmaceutical Industries and Lenskart Solutions led the momentum.
Stocks in news: HDFC Bank, Vedanta Power, YES Bank, Sun Pharma, Waaree Energies
Indian markets surged for a third straight day, buoyed by global sentiment and strong performance from heavyweight stocks like HDFC Bank and YES Bank. Analysts note a technical breakout, though resistance looms. Several companies, including Dabur India and Vedanta Power, reported positive quarterly updates, while Tata Power withdrew a controversial distribution application. ONGC's leadership eligibility criteria have also been broadened.
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1% - The Economic Times
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1%The Economic Times
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1%
Indian stock markets traded mixed on Monday, with Sensex dipping slightly and Nifty inching higher amidst rising oil prices due to Iran-US tensions. While some blue-chips gained, broader markets saw a minor decline. Analysts suggest a potential market upturn due to easing FII selling and South Korea's volatility, but a deficient monsoon remains a concern. Upcoming Q1 results are expected to drive stock-specific movements.
Indian pharma, CDMOs set to gain from US cancer drug supply crunch: Bernstein
Zydus Lifesciences, Lupin and Sun Pharmaceutical Industries could benefit from a US oncology drug supply crunch and India's emerging GLP-1 market opportunity, according to Nandan Kulkarni, Senior Analyst-India Healthcare at Bernstein. He believes Indian biopharma companies are strengthening their role in global healthcare supply chains.
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top Gainers - Equitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top GainersEquitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top Gainers - Equitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top GainersEquitymaster
Stock Picks Today: Coforge, Trent, Colgate, Sun Pharma, Tata Motors PV And More On Brokerages' Radar
Brokerages' Radar
Stocks to watch, June 15: OMCs, paints, ONGC, Oil India, Meesho, Vedanta, Sun Pharma, Dr Reddy's - Upstox
Stocks to watch, June 15: OMCs, paints, ONGC, Oil India, Meesho, Vedanta, Sun Pharma, Dr Reddy'sUpstox
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.